Real ChatGPT answer · index seedWyR5LEGqVSgcompleteHealth and wellness · pharmacies and prescriptionsinformational
What criteria do pharmacy benefit managers use to establish prior authorization requirements for newly approved GLP-one receptor agonists?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What criteria do pharmacy benefit managers use to establish prior authorization requirements for newly approved GLP-one receptor agonists?
2 real searches · 1 real-search pass
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 2 queries…
Searches and sources
ChatGPT2 real searches · gpt-6
pharmacy benefit manager prior authorization criteria GLP-1 receptor agonists newly approved drugs coverage policy clinical criteria 2025 2026 Google ↗
GLP-1 prior authorization criteria PBM FDA approved indication step therapy BMI diabetes obesity coverage policy Google ↗
- Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy · pmc.ncbi.nlm.nih.gov
- Formulary Management · amcp.org
- EX_1080 Pharmacy & Therapeutics Committees in Managed Care Organizations.pdf · ptacts.uspto.gov
- GLP-1 Management Strategies · business.caremark.com
- Weight Loss – Glucagon-Like Peptide-1 Agonists Prior Authorization Policy · static.cigna.com
- Prior authorization and step therapy coverage criteria · bcbsm.com
- 45 CFR § 156.122 - Prescription drug benefits. | Electronic Code of Federal Regulations (e-CFR) | US Law · ec2-174-129-226-102.compute-1.amazonaws.com
- Information for Providers · cms.gov
- Information for Part D Plans · cms.gov
Queries
2 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
pharmacy benefit manager prior authorization criteria GLP-1 receptor agonists newly approved drugs coverage policy clinical criteria 2025 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
GLP-1 prior authorization criteria PBM FDA approved indication step therapy BMI diabetes obesity coverage policy OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |